Stock data
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA) reported revenue of US$67.48M and net income of -US$278.67M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$67.48M | — | -US$303.63M | -US$278.67M | — |
| 2024 | US$53.88M | — | -US$193.19M | -US$173.98M | — |
| 2023 | US$0.00M | — | -US$165.80M | -US$152.63M | — |
| 2022 | — | — | -US$139.87M | -US$135.84M | — |
| 2021 | — | — | — | -US$130.47M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$20.87M | -US$68.33M | — |
| 2026-03-31 | US$18.27M | -US$73.33M | — |
| 2025-12-31 | US$17.34M | -US$81.00M | — |
| 2025-09-30 | US$20.75M | -US$74.12M | — |
| 2025-06-30 | US$15.29M | -US$66.12M | — |
| 2025-03-31 | US$14.11M | -US$57.43M | — |
| 2024-12-31 | — | -US$19.22M | — |
| 2024-09-30 | — | -US$54.40M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.